Cargando…
OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editrice Gastroenterologica Italiana S.r.l.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451187/ http://dx.doi.org/10.1016/S1590-8658(21)00526-0 |
| _version_ | 1784569789282254848 |
|---|---|
| author | Ferretti, F. Cannatelli, R. Monico, M.C. Carvalhas Gabrielli, A.M. Carmagnola, S. Maconi, G. Ardizzone, S. |
| author_facet | Ferretti, F. Cannatelli, R. Monico, M.C. Carvalhas Gabrielli, A.M. Carmagnola, S. Maconi, G. Ardizzone, S. |
| author_sort | Ferretti, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8451187 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editrice Gastroenterologica Italiana S.r.l. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84511872021-09-20 OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY Ferretti, F. Cannatelli, R. Monico, M.C. Carvalhas Gabrielli, A.M. Carmagnola, S. Maconi, G. Ardizzone, S. Dig Liver Dis Oral Communications Editrice Gastroenterologica Italiana S.r.l. 2021-09 2021-09-20 /pmc/articles/PMC8451187/ http://dx.doi.org/10.1016/S1590-8658(21)00526-0 Text en Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. All rights reserved. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Oral Communications Ferretti, F. Cannatelli, R. Monico, M.C. Carvalhas Gabrielli, A.M. Carmagnola, S. Maconi, G. Ardizzone, S. OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
| title | OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
| title_full | OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
| title_fullStr | OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
| title_full_unstemmed | OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
| title_short | OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY |
| title_sort | oc.06.7 lower incidence of covid-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy |
| topic | Oral Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451187/ http://dx.doi.org/10.1016/S1590-8658(21)00526-0 |
| work_keys_str_mv | AT ferrettif oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy AT cannatellir oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy AT monicomc oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy AT carvalhasgabrielliam oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy AT carmagnolas oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy AT maconig oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy AT ardizzones oc067lowerincidenceofcovid19inpatientswithinflammatoryboweldiseasetreatedwithnongutselectivebiologictherapy |